Process View
The process whose specific outcome is the progression of the mammary gland over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk. Its development starts with the formation of the mammary line and ends as the mature gland cycles between nursing and weaning stages.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "mammary gland development"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
ESR1 | estrogen receptor 1 | 0.989 | Mouse | |
EGFR | epidermal growth factor receptor | 0.986 | Human | |
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.981 | ||
CREBBP | CREB binding protein | 0.869 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.819 | ||
INSR | insulin receptor | 0.783 | ||
IGF1R | insulin-like growth factor 1 receptor | 0.765 | Mouse | |
FGFR2 | fibroblast growth factor receptor 2 | 0.700 | Mouse | |
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.640 | Human Rat | |
NCOA1 | nuclear receptor coactivator 1 | 0.556 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.523 | ||
JAG1 | jagged 1 | 0.503 | ||
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.300 | ||
GRB10 | growth factor receptor-bound protein 10 | 0.280 | ||
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.266 | ||
IRS1 | insulin receptor substrate 1 | 0.238 | Mouse | |
NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.226 | ||
AR | androgen receptor | 0.169 | Mouse | |
EP300 | E1A binding protein p300 | 0.161 | ||
RUNX1 | runt-related transcription factor 1 | 0.134 | ||
PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.132 | ||
STAT5A | signal transducer and activator of transcription 5A | 0.125 | Mouse Rat | |
GSK3B | glycogen synthase kinase 3 beta | 0.121 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.110 | ||
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.110 | ||
RARA | retinoic acid receptor, alpha | 0.107 | ||
NCOA2 | nuclear receptor coactivator 2 | 0.103 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.103 | Human Rat | |
CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.092 | ||
FGF1 | fibroblast growth factor 1 (acidic) | 0.092 | Human | |
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.091 | Mouse | |
IL4R | interleukin 4 receptor | 0.081 | ||
SP1 | Sp1 transcription factor | 0.075 | ||
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.075 | ||
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.073 | ||
GHR | growth hormone receptor | 0.069 | ||
NRP1 | neuropilin 1 | 0.069 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.064 | ||
TRIP6 | thyroid hormone receptor interactor 6 | 0.064 | ||
EHF | ets homologous factor | 0.064 | ||
APC | adenomatous polyposis coli | 0.061 | ||
ENG | endoglin | 0.058 | ||
NCOA3 | nuclear receptor coactivator 3 | 0.058 | Mouse | |
SH2B1 | SH2B adaptor protein 1 | 0.055 | ||
SMAD2 | SMAD family member 2 | 0.052 | ||
FGF10 | fibroblast growth factor 10 | 0.051 | ||
RXRA | retinoid X receptor, alpha | 0.048 | ||
MEOX2 | mesenchyme homeobox 2 | 0.045 | ||
TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.043 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.043 | Mouse | |
KAT2B | K(lysine) acetyltransferase 2B | 0.041 | ||
STAT5B | signal transducer and activator of transcription 5B | 0.040 | Mouse | |
CCND3 | cyclin D3 | 0.040 | ||
CDK6 | cyclin-dependent kinase 6 | 0.040 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.037 | ||
LDLR | low density lipoprotein receptor | 0.035 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.035 | ||
CCND1 | cyclin D1 | 0.033 | Mouse | |
HIPK2 | homeodomain interacting protein kinase 2 | 0.033 | ||
BCL9 | B-cell CLL/lymphoma 9 | 0.033 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.031 | ||
TM4SF1 | transmembrane 4 L six family member 1 | 0.031 | ||
EFNA1 | ephrin-A1 | 0.030 | ||
EPOR | erythropoietin receptor | 0.029 | ||
S100A4 | S100 calcium binding protein A4 | 0.029 | ||
FOXO1 | forkhead box O1 | 0.029 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.027 | ||
BCL2 | B-cell CLL/lymphoma 2 | 0.026 | ||
FZD1 | frizzled homolog 1 (Drosophila) | 0.026 | ||
CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.025 | ||
PPARA | peroxisome proliferator-activated receptor alpha | 0.025 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.025 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.025 | ||
NCOR2 | nuclear receptor corepressor 2 | 0.024 | Rat | |
CDK4 | cyclin-dependent kinase 4 | 0.023 | ||
CUEDC2 | CUE domain containing 2 | 0.022 | ||
LAT | linker for activation of T cells | 0.022 | ||
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.021 | ||
EPAS1 | endothelial PAS domain protein 1 | 0.021 | ||
PDZD11 | PDZ domain containing 11 | 0.021 | ||
MSX1 | msh homeobox 1 | 0.021 | Mouse | |
FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.020 | ||
PLCG1 | phospholipase C, gamma 1 | 0.020 | ||
BBS10 | Bardet-Biedl syndrome 10 | 0.020 | ||
MED25 | mediator complex subunit 25 | 0.020 | ||
JDP2 | Jun dimerization protein 2 | 0.020 | ||
RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.019 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.018 | ||
CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.018 | ||
CALCA | calcitonin-related polypeptide alpha | 0.018 | ||
MEIS1 | Meis homeobox 1 | 0.018 | ||
WNT1 | wingless-type MMTV integration site family, member 1 | 0.018 | Human | |
KLF13 | Kruppel-like factor 13 | 0.018 | ||
FGF18 | fibroblast growth factor 18 | 0.018 | ||
SFRP1 | secreted frizzled-related protein 1 | 0.017 | ||
CDK8 | cyclin-dependent kinase 8 | 0.017 | ||
HR | hairless homolog (mouse) | 0.017 | ||
PGF | placental growth factor | 0.017 | ||
LRP6 | low density lipoprotein receptor-related protein 6 | 0.017 | Mouse | |
APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | 0.017 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.017 | ||
SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.017 | ||
MUC1 | mucin 1, cell surface associated | 0.017 | ||
STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.016 | ||
NCOA6 | nuclear receptor coactivator 6 | 0.016 | ||
TGFB3 | transforming growth factor, beta 3 | 0.016 | Mouse | |
FOXO3 | forkhead box O3 | 0.016 | ||
PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.016 | ||
WNT3A | wingless-type MMTV integration site family, member 3A | 0.015 | Mouse | |
POU3F2 | POU class 3 homeobox 2 | 0.015 | ||
S100A2 | S100 calcium binding protein A2 | 0.015 | ||
PPP5C | protein phosphatase 5, catalytic subunit | 0.015 | ||
UBQLN4 | ubiquilin 4 | 0.015 | ||
FGF7 | fibroblast growth factor 7 | 0.015 | Human | |
SMAD3 | SMAD family member 3 | 0.015 | ||
PGR | progesterone receptor | 0.015 | Mouse | |
NOTCH2NL | notch 2 N-terminal like | 0.015 | ||
GATA2 | GATA binding protein 2 | 0.015 | Human | |
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.015 | Rat | |
AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.014 | ||
CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.014 | ||
NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | 0.014 | Mouse | |
RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.014 | ||
DLL1 | delta-like 1 (Drosophila) | 0.014 | ||
NCOR1 | nuclear receptor corepressor 1 | 0.013 | ||
BARX1 | BARX homeobox 1 | 0.013 | ||
PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.013 | ||
FHL2 | four and a half LIM domains 2 | 0.013 | ||
SFRP5 | secreted frizzled-related protein 5 | 0.013 | ||
CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.013 | ||
PHLPP1 | PH domain and leucine rich repeat protein phosphatase 1 | 0.013 | ||
EPT1 | ethanolaminephosphotransferase 1 (CDP-ethanolamine-specific) | 0.013 | ||
JAG2 | jagged 2 | 0.012 | ||
THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.012 | ||
FRZB | frizzled-related protein | 0.012 | ||
PML | promyelocytic leukemia | 0.012 | ||
USF1 | upstream transcription factor 1 | 0.012 | ||
TBX2 | T-box 2 | 0.012 | ||
APBB2 | amyloid beta (A4) precursor protein-binding, family B, member 2 | 0.012 | ||
DLG2 | discs, large homolog 2 (Drosophila) | 0.012 | ||
FZD7 | frizzled homolog 7 (Drosophila) | 0.012 | ||
BRCA1 | breast cancer 1, early onset | 0.012 | ||
PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.011 | ||
MTA1 | metastasis associated 1 | 0.011 | ||
TGFB2 | transforming growth factor, beta 2 | 0.011 | ||
FBLN1 | fibulin 1 | 0.011 | ||
CPE | carboxypeptidase E | 0.011 | ||
DKK1 | dickkopf homolog 1 (Xenopus laevis) | 0.011 | ||
MSX2 | msh homeobox 2 | 0.011 | Mouse | |
TLE1 | transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) | 0.011 | ||
SHC3 | SHC (Src homology 2 domain containing) transforming protein 3 | 0.011 | ||
FGF3 | fibroblast growth factor 3 | 0.011 | Human | |
ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.011 | ||
RUNX1T1 | runt-related transcription factor 1; translocated to, 1 (cyclin D-related) | 0.010 | ||
ZFPM1 | zinc finger protein, multitype 1 | 0.010 | ||
DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.010 | ||
FSTL1 | follistatin-like 1 | 0.010 | ||
RNF144B | ring finger protein 144B | 0.010 |